NCT01871961View on ClinicalTrials.gov

Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

PHASE1CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

May 31, 2013

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG

Methotrexate (Metoject® prefilled pen)

Trial Locations (1)

33143

Rheumatology Arthitis & Rheumatic Care center, South Miami

Sponsors

Collaborators (1)

PPD Development, LP

All Listed Sponsors

collaborator

PPD Development, LP

INDUSTRY

lead

medac GmbH

INDUSTRY